PROTEINZIELKOMPLEX

European patent · EP2812692 · In force

Register entry

Publication number
EP2812692
Application number
EP13710588
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 6, 2013
Published
Dec 17, 2014
Granted
Jul 15, 2020
Protection ends at the latest
Feb 5, 2033
Next annual fee due
Feb 28, 2027
IPC classes
G01N 33/50 (2006.01)
Priority
NL 2008241 06.02.2012
PCT application
PCT/NL2013/050067 06.02.2013
PCT publication
WO2013/119114 15.08.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 31, 2026

    Next annual fee due on

    Next annual fee due on
    28.02.2026 → 28.02.2027

    Published in Swissreg on 31.08.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    28.02.2025 → 28.02.2026

    Published in Swissreg on 01.09.2025

  3. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  4. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  5. Jul 15, 2020

    Granted

    Published in Swissreg on 15.07.2020

Parties

Holder

HQ Medical (Netherlands) B.V.

Delftweg 96, 3043 NA Rotterdam, NL

Publiekrechtelijke rechtspersoon Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum

Albinusdreef 2, 2333 ZA Leiden, NL

Inventor

MARING, Markwin Hendrik

NL-3400 AC Rotterdam, NL

LÖWIK, Clemens Waltherus Gerardus

NL-3400 AC Rotterdam, NL

VAN BEEK, Ermond Reijer

NL-3400 AC Rotterdam, NL

Licensee

Academisch Ziekenhuis Leiden LUMC

Albinusdreef 2, 2333 ZA Leiden, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.